Similar articles

• Properties of anti-dog lymphocytic globulin raised with two cell types and immunization schedules.

  Collste LG, Groth CG, Kashiwagi N, Schantz B, Svehag SE. Collste LG, et al. Acta Chir Scand. 1972;138(8):775-80. Acta Chir Scand. 1972. PMID: 4565722 No abstract available.
• Purification and in vitro properties of antihuman and anti-macaca thymocyte IgG, comparison of prolonged and pulse immunization, and the use of macaca thymocytes to conserve human antigen.

  Svehag SE, Haxner P, Schilling W, Falksveden L. Svehag SE, et al. Transplantation. 1971 Mar;11(3):274-87. doi: 10.1097/00007890-197103000-00006. Transplantation. 1971. PMID: 4997636 No abstract available.
• Studies on red cell aplasia. 3. Treatment with horse antihuman thymocyte gamma globulin.

  Krantz SB. Krantz SB. Blood. 1972 Mar;39(3):347-60. Blood. 1972. PMID: 4110433 No abstract available.
• The clinical use of antilymphocyte globulin.

  Najarian JS, Simmons RL. Najarian JS, et al. N Engl J Med. 1971 Jul 15;285(3):158-66. doi: 10.1056/NEJM197107152850310. N Engl J Med. 1971. PMID: 4103453 Review. No abstract available.
• Mechanisms of immunosuppression by antilymphocyte antibody.

  Taub RN. Taub RN. Pathobiol Annu. 1972;2:129-51. Pathobiol Annu. 1972. PMID: 4149315 Review. No abstract available.